Ceftriaxone-induced neurotoxicity in a patient after pancreas-kidney transplantation

Hideharu Hagiya, Koji Miyawaki, Norihisa Yamamoto, Hisao Yoshida, Akihiro Kitagawa, Tadafumi Asaoka, Hidetoshi Eguchi, Yukihiro Akeda, Kazunori Tomono

研究成果: Contribution to journalArticle

3 引用 (Scopus)


Ceftriaxone is a widely used third-generation cephalosporin showing advantageous pharmacokinetic properties and a broad antimicrobial spectrum. We herein report a case of ceftriaxone-induced neurotoxicity in a 56-year-old man on hemodialysis. Seven days after initiating high-dose ceftriaxone, the patient developed impaired consciousness along with facial myoclonus and sporadic phonation. The symptoms clearly disappeared shortly after withdrawal of the drug. Ceftriaxone is considered a safe antibiotic for patients with renal insufficiency, since it is excreted via both haptic and renal pathways. Physicians should note that antibiotic-associated encephalopathy may develop in patients administered ceftriaxone, especially in those complicated with renal dysfunction.

ジャーナルInternal Medicine
出版物ステータス出版済み - 2017

All Science Journal Classification (ASJC) codes

  • Internal Medicine

フィンガープリント Ceftriaxone-induced neurotoxicity in a patient after pancreas-kidney transplantation' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Hagiya, H., Miyawaki, K., Yamamoto, N., Yoshida, H., Kitagawa, A., Asaoka, T., Eguchi, H., Akeda, Y., & Tomono, K. (2017). Ceftriaxone-induced neurotoxicity in a patient after pancreas-kidney transplantation. Internal Medicine, 56(22), 3103-3107. https://doi.org/10.2169/internalmedicine.8774-16